MelbImmunoNetwork
@MelbImmunoNet
Followers
407
Following
247
Media
57
Statuses
224
The latest #immunotherapy news from Melbourne and beyond. Driving academic, industry & clinical collabs. https://t.co/ZucxKmvU6T Ash H & Anne F tweeting
Melbourne, Victoria
Joined March 2017
Amazing lineup of speakers for our annual immunotherapy meeting. It's an affordable, collegiate meeting with lots of scientific, clinical and industry interaction. Abstract submissions and early registration close 21st July. Hope to see you! Register at: https://t.co/SMV9MazqMS
0
5
9
The latest review from our lab: B cells, IEI/PID, immune memory, allergy. A journey thru 30 yrs of my research. But really a tribute to terrific PhD students who worked on these topics during the past 20 yrs Immunological Reviews https://t.co/tiumdlvkVS
onlinelibrary.wiley.com
The essential role of B cells is to produce protective immunoglobulins (Ig) that recognize, neutralize, and clear invading pathogens. This results from the integration of signals provided by pathog...
2
17
60
Looking for an exciting new challenge in 2024? @DeenickLab is looking for postdoc keen to study the mechanisms of immunodeficiency and autoimmunity. Working with a great team of scientists in the precision immunology program @GarvanInstitute
https://t.co/AyYwmhoTVd
1
22
37
Fantastic to share new work led by @SarahKWhiteside published today in @SciImmunology. We find that CD4+ conventional T cells acquire suppressive functions upon Treg depletion limiting efficacy of Treg-targeted therapies. Collaboration with @luglilab🧵👇 https://t.co/5TPfwxf2jq
science.org
CCR8+ Tconv cells undergo expansion and activation upon Treg cell depletion and limit antitumor immunity through production of IL-10.
10
49
175
Re-advertising for an RA. Please circulate again: looking for someone with good molecular (cloning, NGS a bonus), cellular (culture, multiparameter FACS), lab organisation skills, and love working with different people and new tech!
1
36
45
Dear immuno-enthusiasts, pls consider registering for this translational immunology conference in Melbourne 14-17 May 2024. We will have loads of international and national speakers! and it's at MARVEL STADIUM! https://t.co/gfQkvjmOxv
0
5
7
Completed Honours, Masters or PhD in immunology? We are recruiting! If you’re interested in T cell immunity, in vivo models, flow cytometry, scRNAseq, Spatial Transcriptomics, intravital imaging, CRISPR/Cas9 etc, contact me via email to discuss @TheDohertyInst @UniMelbMDHS
2
20
55
Dear #globalimmuno We are excited to solicit nominations for 2024 #globalimmuno speakers! Please enter your nomination/s via this link BEFORE Nov 3rd https://t.co/svwCsuMG5B Only nominations in the link will be considered Please RT 🙏
docs.google.com
We invite the #GlobalImmuno community to suggest speakers for future Global Immunotalks. Nominations will be reviewed by the Global Immunotalks organizers before each semester’s schedule is finaliz...
1
31
38
Excited to share this work. I think we finally understand why a particular cDC2 subset is required specifically for Th2 fate instruction at the time of CD4T cell priming.
Rapid activation of IL-2 receptor signaling by CD301b+DC-derived IL-2 dictates the outcome of helper T cell differentiation https://t.co/DGtlUiby7o
#biorxiv_immuno
2
12
68
Absolutely fantastic news, can't wait for this. Congratulations to all involved in the bid.
Our bid to host the 2025 World Cancer Leader’s Summit with @cancervic, @MonashPCCC and @McCabe_Centre has been successful. I couldn't be more proud to welcome this event to Victoria and showcase our world-class hub of cancer innovation and care. https://t.co/fOAASKGWrP
@uicc
0
0
0
Pancreatic cancer is so hard to treat and harder to diagnose! Key messages from the 2023 @PanKind_APCF #PanKindScience23 Early Detection Workshop: We need to work together, involve communities in all aspects of research, and address disparities and inequalities in care.
0
1
12
We are excited to share an IUIS-FOCIS Scholarship Opportunity for our 2024 Advanced Course in Basic and Clinical Immunology in La Jolla, CA! We are covering $2K, registration, accommodation, and meals for recipients! Learn more and apply here https://t.co/T5BdSDuNH2 by Nov 1st.
0
12
18
Stem-like exhausted and memory CD8 T cells are a hot topic in cancer immunology & immunotherapy. But what exactly are these cells and why do they matter? Thomas Gebhardt, @simpak and I cover this & more in our latest review @NatureRevCancer
4
64
198
Congratulations @UtzschneiderD !
Boosting exhausted T cells: Dr Daniel Utzschneider has identified how T cells can become exhausted from battling cancer, reducing the effectiveness of immunotherapy. He will use his CSL Centenary Fellowship to study these cells. @TheDohertyInst
https://t.co/KytXyaExsR
0
0
3
Definitely going to try this out
I once saw someone refer to their PBMC ficoll process taking 2.5 hrs so I want to put our lab's SOP out there. Saves tonnes of ⏱ without compromising quality 👌 Just pop and drop those pipettes of ficoll 😎
0
0
1
A new study by @LouisPerriman @DanielPellicci characterizes a less-studied group of unconventional T cells, establishing that they can develop in the thymus after birth. Learn more: https://t.co/pRwYvz3933
1
14
38
We are recruiting! Looking for an excellent immunologist to join my Unimelb lab as a research officer/post doc on flu and COVID projects
4
31
44
🥳 Excited to announce new #onjcri @ScIimmunology publication – 5 years in the making from @Mielke_Lisa & team (@MarinaYakou @Sonia_Ghi Kelly Tran). World-first discovery: Targeted deletion of TCF-1 on gamma delta T cells reduced #bowelcancer tumours https://t.co/FXkf6OC0I8
2
12
60
So many bots following this account lately, check out our two latest with identical text, they don't even try any more. (I don't mean you @MeredithKeeffe ! 😂 you're very real, thanks for the follow) Are others having this issue?
0
0
2
Great opportunity
📢 The Antiviral Immunity team @BurnetInstitute is recruiting! Are you interested in applying your immunology skills to improving patients outcomes in the clinic? We're looking for a RA or RO to contribute to our COVID-19 vaccine & other virus studies 👇 https://t.co/HhiLmSjGcw
0
0
0
Great study, congratulations @ReneaTaylor1 , Gail Risbridger and teams
See our latest publication in @NatureComms on prostate cancer CAR T cell efficacy. Preclinical studies provide proof of concept that modifying the #TME enhances T cell trafficking and activation @MonashBDI @PeterMacRes #prostatecancer #CARTcells
https://t.co/Qij2IUvmNr
0
0
0